Discriminant prognostic parameters in and between early and advanced stages of renal cell carcinoma;Parametri qualitativi e quantitativi per la prognosi del carcinoma renale in stadio precoce ed avanzato

Pathologica

Volumn 89, Issue 4, 1997, Pages 390-396

  Del Vecchio, M T ^b   Spina, D ^b   Lazzi, S ^b   Bruni, A ^b   Funto I ^b   Mattei, F M ^a   Fornaini, M ^a   Luzi, P ^b   Tosi, P ^b  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Carcinoma, renal cell; Nucleus Cell cycle DNA; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER STAGING; CELL CYCLE S PHASE; CELL NUCLEUS; CHEMISTRY; COMPARATIVE STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MITOSIS INDEX; MORTALITY; PATHOLOGY; PLOIDY; PROGNOSIS; SURVIVAL; ULTRASTRUCTURE;

ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARCINOMA, RENAL CELL; CELL NUCLEUS; DNA, NEOPLASM; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MITOTIC INDEX; NEOPLASM PROTEINS; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR; S PHASE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031196909     PISSN: 00312983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Trasher JB, Paulson DF. Prognostic factors in renal cancer. Urol Clin North America 1993;20:247-262.
2. Nativ O, Sabo E, Bejar J, Halachmi S, Moskovitz B, Miselevich I. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma. British J Urol 1996;78:33-38.
3. Frank W, Guinan P, Stuhldreher D, Saffrin R, Ray P, Rubenstein M. Renal cell carcinoma: the size variable. J Surg Oncol 1993;54:163-166.
4. Syrjänen K, Hjelt L. Grading of human renal adenocarcinoma. Scand J Urol Nephrol 1978;12:49-55.
5. Bot FJ, Goldschalk JCJ, Krishnadath KK, van der Kwast THM, Bosman FT. Prognostic factors in renal-cell carcinoma: immunohistochemical detection of p53 protein versus clinico-pathological parameters. Int J Cancer 1994;57:634-637.
6. Lipponen P, Eskelinen M, Hietala K, Syrianen K. Expression of proliferating cell nuclear antigen (PC10, p53 protein and c-erbB-2 in renal adenocarcinoma. Int J Cancer 1994;57:275-28.
7. Bibbo M, Galera-Davidson H, Dytch HE, Gonzales de Chaves J, Lopes-Garrido J, Baitels PH, et al. Karyometry and histometry of renal-cell carcinoma. Anal Quant Cytol Ematol 1987;9:182-187.
8. Murphy GF, Partin AW, Maygarden SJ, Mohler JL. Nuclear shape analysis for assessment of prognosis in renal cell carcinoma. J Urol 1990;143:1103-1107.
9. Tosi P, Luzi P, Baak JPA, Miracco C, Santopietro R, Vindigni C, et al. Nuclear morphometry as an important prognostic factors in stage I renal cell carcinoma. Cancer 1986;58:2512-2518.
10. Eskelinen M, Lipponen P, Aitto-Oja L, Hall O, Syrianen K. The value of histoquantitative measurements in prognostic assessment of renal carcinoma. Int J Cancer 1993;55:547-554.
11. Di Silverio F, Gallucci M, Flammia GP, De Vico A, Caponera M, Eleuteri P, et al. Biological and clinical implication of cellular DNA content in renal cell carcinomas. Eur Urol 1992;21:43-47.
12. Grignon DJ, Abdel-Malak M, Mertens W, Koster J, Keeney M, Sakr W, et al. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index. Mod Pathol 1995;8:18-24.
13. Yu DS, Hzu CM, Lee WH, Chang SY, Ma CP. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis. J Surg Res 1993;55:480-485.
14. Abubakr JA, Chou TH, Redman BG. Spontaneous remission of renal cell carcinoma: a case report and immunological correlates. J Urol 1994;152:156-157.
15. Kudoh S, Stanley J, Edinger MG, Tubbs RR, Klein E, Bukowski RM, et al. T lymphocytes infiltrating renal cell carcinoma have a reduced expression of trasferrin receptor. Int J Cancer 1994;58:369-375.
16. Thiounn N, Mathiot C, Tartour E, Joyeux I, Peyret C, Brandelyn M, et al.Phenotypic and functional analysis of tumor-infiltrating lymphocytes from patients with renal cell carcinoma. Eur Urol 1994;25:151-157.
17. Damhuis RAM, Blom JHM. The influence of age on treatment choice and survival in 735 patients with renal carcinoma. Br J Urol 1995;75:143-147.
18. Robson CJ, Churchill BM, Andersen W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297-301.
19. Hermanek P, Schrott KM. Evaluation of the new tumor, nodes and metastasis classification of renal cell carcinoma. J Urol 1990;144:238-242.
20. Luzi P, Bruni A, Mangiavacchi P, Cevenini C, Marini D, Tosi P. Ploidy pattern and cell cycle in breast cancer as detected by image analysis and flow cytometry. Cytometry 1994;18:79-87.
21. Wilkinson L. SYSTAT, The system for statistic. Evanston IL: SYSTAT Inc 1989.
22. Morrison DF. Multivariate statistical methods. New York: McGraw-Hill 1976.
23. Lanigan D, Conroy R, Walsh CB, Loftus B, Royston D, Leader M. A comparative analysis of grading system in renal adenocarcinoma. Histopathology 1994;24:473-476.
24. Donhuijsen K, Schulz S, Dietrich Leder L. Nuclear grading of renal cell carcinomas-is morphometry necessary? J Cancer Res Clin Oncol 1991;117:73-78.
25. Delahunt B, Bethwaite PB, Nacey JN, Ribas JL. Proliferating cell nuclear antigen (PCNA expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. J Pathol 1993;170:471-477.
26. Larsson P, Roos G, Stenling R, Lyungberg B. Tumor-cell proliferation and prognosis in renal-cell carcinoma. Int J Cancer 1993;55:566-570.
27. Lager DJ, Slagel DD, Palechek PL. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. Mod Pathol 1994;7:544-548.